美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

美国抗疫概念

1,873.71

+27.651.50%

涨家数：17

跌家数：2

平家数：- -

市盈率：- -

高：1,876.03

开：1,846.57

低：1,846.57

收：1,846.06

成交量：1.92亿

成交额：91.72亿

市值：1.52万亿

流通市值：1.49万亿

数据加载中...

总览新闻资讯

ARISTA网络：大股东Andreas Bechtolsheim拟出售30万股，市值约5985.90万美元

南方财经网

百事：选举强生CEO Joaquin Duato为新任董事

南方财经网

辉瑞加拿大：疫苗将在未来数日及数周内通过多种分发渠道供应

加拿大辉瑞公司：未来数天至数周内，疫苗将通过多种分销渠道供应。

加拿大卫生部批准辉瑞XFG适配版新冠疫苗。

Moderna Inc(MRNA)股票9月17日盘中上涨7.25%：真相来了

TradingKey中文

AETHLON MEDICAL与NORTH IMMUNOLOGY达成合并协议后，股价飙升467%至8.16美元。

Aethlon Medical与North Immunology合并后股价飙升

Aethlon Medical宣布与North Immunology达成合并协议，盘前股价飙升87.4%至2.68美元

Aethlon Medical：合并前原股东持股约4.75%，North Immunology股东将掌控合并后公司约95.25%股权

Aethlon Medical合并案揭晓：North Immunology原股东预计持有合并实体约95.25%股份

Aethlon Medical与North Immunology合并，共推新型IL-13×IL-18双特异性抗体治疗特应性皮炎

Co-Diagnostics携手Readygo，共探血液分子即时检测——首站瞄准埃博拉病毒

吉利德科学扩大六项免许可费自愿授权协议，力推每年一次HIV预防药Lenacapavir

钨价两年九倍，“工业牙齿”打响全球争夺战

Co-Diagnostics签署重要材料转让协议——与Readygo Diagnostics达成合作，2026年8月生效（SEC文件披露）

健康快讯：一种用于磁共振成像检查的新造影剂可更早发现肺癌

Contineum 股价下跌 9.9%，原因是其与强生合作研发的抗抑郁药中期临床试验失败。

吉利德科学携手巴西卫生部，共促Lenacapavir本地化生产新篇章

吉利德科学：持续探索与泛美卫生组织合作，助力各国准备好并扩大长效艾滋病预防措施的普及

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.etasphere.com/hans/stock/BK4568/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK4568","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","market":"US","secType":"PLATE","nameCN":"美国抗疫概念","latestPrice":1873.7128,"timestamp":1789675199999,"preClose":1846.0641,"halted":0,"volume":191798491,"delay":0,"changeRate":0.014977,"floatShares":0,"shares":0,"eps":0,"marketStatus":"未开盘","change":27.648682,"latestTime":"09-17 16:00:00 EDT","open":1846.5702,"high":1876.0276,"low":1846.5702,"amount":9172356719.329176,"amplitude":0.015957,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1789738200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"pbRate":4.827206,"peRate":46.939197,"turnoverRate":0.013824,"increases":17,"decrements":2,"flats":0,"marketCap":1524158679630.5,"floatMarketCap":1489113956687.5},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK4568\",,,,,undefined,":{"symbol":"BK4568","high":1876.0276,"amplitude":0.015957,"preClose":1846.0641,"low":1846.5702,"pbRate":"4.827206","latestPrice":1873.7128,"volume":191798491,"delay":0,"open":1846.5702,"prevYearClose":1637.1339,"prevWeekClose":1829.725,"prevMonthClose":1860.7577,"prevQuarterClose":1731.2963,"fiveDayClose":1831.6982,"twentyDayClose":1917.3663,"sixtyDayClose":1669.3518,"secType":"PLATE","market":"US","turnoverRate":0.013824,"peRate":46.939197,"marketCap":1524158679630.5,"floatMarketCap":1489113956687.5,"timestamp":1789675199999,"nameCN":"美国抗疫概念"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK4568\",,,,undefined,":{"bkCode":"BK4568","up":17,"down":2,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK4568\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2668901099","title":"ARISTA网络：大股东Andreas Bechtolsheim拟出售30万股，市值约5985.90万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2668901099","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668901099?lang=zh_cn&edition=fundamental","pubTime":"2026-09-18 06:38","pubTimestamp":1789684680,"startTime":"0","endTime":"0","summary":"南财智讯9月18日电，ARISTA网络（AristaNetworks,Inc.，纽约证券交易所：ANET）10%股东AndreasBechtolsheim提交Form144限制股出售声明。AndreasBechtolsheim拟出售30万股普通股，合计市值约5985.90万美元，拟出售日期为9月17日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609183877710385.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609183877710385.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4568","BK4551","BK4585","BK4535","BK4548","BK4139","BNTX","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668699048","title":"百事：选举强生CEO Joaquin Duato为新任董事","url":"https://stock-news.laohu8.com/highlight/detail?id=2668699048","media":"南方财经网","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668699048?lang=zh_cn&edition=fundamental","pubTime":"2026-09-18 06:38","pubTimestamp":1789684680,"startTime":"0","endTime":"0","summary":"南财智讯9月18日电，百事（PepsiCo,Inc.，纳斯达克：PEP）提交8-K报告，披露9月17日选举新董事事项。公司董事会选举JoaquinDuato为独立董事，自2026年12月1日起生效，届时将担任董事会审计委员会成员。Duato现年64岁，自2023年起担任强生董事会主席，自2022年起兼任首席执行官。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202609183877710287.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202609183877710287.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["FHLC","IE0001KFT4U8.USD","IE0002141913.USD","MEDX","LU0820561818.USD","LU0098860793.USD","LU1043141396.HKD","SG9999002232.USD","LU0234570918.USD","RXL","BMED","LU0289739343.SGD","LU1585245621.USD","LU0787776722.HKD","XLV","IE00B4R5TH58.HKD","LU0426412945.USD","LU0882574055.USD","LU1244550577.SGD","LU0985320562.USD","LU1935042991.SGD","IXJ","FTXH","IE00BGHQF631.EUR","IHE","LU2129689514.USD","BK4534","JDOC","LU2471134879.HKD","LU0203347892.USD","SG9999001440.SGD","LU0234572021.USD","LU1032955483.USD","TRUH","PJP","IYH","JNJ","LU0795875086.SGD","LU0795875169.SGD","LU2487616109.SGD","IE0034235303.USD","VHT","LU1929549753.HKD","BK4568","LU1061106388.HKD","LU0210528500.USD","LU0069063385.USD","GDOC","LU1043141123.HKD","LU0964807845.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119711682","title":"辉瑞加拿大：疫苗将在未来数日及数周内通过多种分发渠道供应","url":"https://stock-news.laohu8.com/highlight/detail?id=1119711682","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119711682?lang=zh_cn&edition=fundamental","pubTime":"2026-09-18 01:32","pubTimestamp":1789666349,"startTime":"0","endTime":"0","summary":"辉瑞加拿大公司表示，疫苗预计将在未来几天乃至数周内，经由多种不同的分发渠道逐步向公众提供。此举旨在扩大疫苗的可及性，确保更多人群能够尽快获得接种机会。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0225284248.USD","IE00B3T34201.USD","BK4533","LU1894683348.USD","IE00BLSP4452.SGD","SG9999001176.SGD","LU0170899867.USD","SG9999003800.SGD","SGXZ57979304.SGD","BK4588","BK4599","OZEM","LU0306806265.USD","LU1057294990.SGD","PFE","LU0289739699.SGD","SG9999013999.USD","BK4550","LU0234572021.USD","LU0868494617.USD","BK4568","LU1023059063.AUD","LU1066051498.USD","IE000M9KFDE8.USD","SG9999002224.SGD","LU2596442595.SGD","SG9999002232.USD","IE00BBT3K403.USD","LU0058720904.USD","IE0002270589.USD","LU0122379950.USD","BK4007","LU0321505439.SGD","LU0321505868.SGD","LU0456855351.SGD","LU1894683264.USD","SG9999011175.SGD","LU0306807586.USD","LU1066053197.SGD","BK4592","IE00BLSP4239.USD","BK4581","BK4534","LU0985481810.HKD","IE00B19Z3B42.SGD","BK4585","IE00B19Z3581.USD","LU0225771236.USD","SG9999001176.USD","LU1883839398.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668859991","title":"加拿大辉瑞公司：未来数天至数周内，疫苗将通过多种分销渠道供应。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668859991","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668859991?lang=zh_cn&edition=fundamental","pubTime":"2026-09-18 01:31","pubTimestamp":1789666302,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0456855351.SGD","SGXZ57979304.SGD","SG9999001176.SGD","LU0225284248.USD","BK4585","LU0225771236.USD","LU1023059063.AUD","SG9999002232.USD","LU1894683264.USD","SG9999002224.SGD","SG9999001176.USD","BK4568","IE00BLSP4452.SGD","PFE","IE00BBT3K403.USD","LU0122379950.USD","LU0321505868.SGD","BK4534","LU1066053197.SGD","BK4007","SG9999011175.SGD","SG9999003800.SGD","LU0058720904.USD","BK4588","LU2596442595.SGD","LU0306806265.USD","IE0002270589.USD","LU0170899867.USD","LU0985481810.HKD","BK4592","IE00B3T34201.USD","LU0289739699.SGD","IE00B19Z3B42.SGD","SG9999013999.USD","BK4533","IE000M9KFDE8.USD","IE00BLSP4239.USD","LU0234572021.USD","BK4581","LU1057294990.SGD","LU1883839398.USD","BK4599","IE00B19Z3581.USD","LU0321505439.SGD","LU0868494617.USD","LU1066051498.USD","OZEM","BK4550","LU1894683348.USD","LU0306807586.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668991839","title":"加拿大卫生部批准辉瑞XFG适配版新冠疫苗。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668991839","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668991839?lang=zh_cn&edition=fundamental","pubTime":"2026-09-18 01:31","pubTimestamp":1789666275,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU0225771236.USD","BK4581","LU1894683264.USD","LU0289739699.SGD","IE0002270589.USD","LU0225284248.USD","SG9999002224.SGD","IE00BLSP4239.USD","LU0058720904.USD","LU1883839398.USD","SG9999001176.USD","IE00BLSP4452.SGD","IE00B19Z3B42.SGD","OZEM","IE00B19Z3581.USD","LU0122379950.USD","BK4592","SGXZ57979304.SGD","LU0306807586.USD","BK4599","LU0321505439.SGD","LU1023059063.AUD","PFE","LU0456855351.SGD","LU1066053197.SGD","LU0868494617.USD","LU0170899867.USD","SG9999003800.SGD","LU2596442595.SGD","SG9999002232.USD","IE000M9KFDE8.USD","BK4007","BK4533","LU0985481810.HKD","SG9999001176.SGD","BK4534","LU0321505868.SGD","BK4588","SG9999013999.USD","BK4585","BK4550","LU1894683348.USD","LU0234572021.USD","IE00B3T34201.USD","IE00BBT3K403.USD","LU1057294990.SGD","SG9999011175.SGD","LU0306806265.USD","BK4568","LU1066051498.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668991375","title":"Moderna Inc(MRNA)股票9月17日盘中上涨7.25%：真相来了","url":"https://stock-news.laohu8.com/highlight/detail?id=2668991375","media":"TradingKey中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668991375?lang=zh_cn&edition=fundamental","pubTime":"2026-09-18 01:16","pubTimestamp":1789665375,"startTime":"0","endTime":"0","summary":"• 宏观经济利好与风险偏好升温推动了莫德纳股价强劲上涨与剧烈波动。\n• intismeran 的积极晚期临床数据提升了对其肿瘤管线的估值预期。\n• 分析师上调评级与机构需求消化了内部人士例行减持带来的抛压。","market":"us","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262173724-market-movers-mrna-20260917","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4501","MRNY","BK4568","BK4588","BK4139","WDNA","BK4585","MRNX","BK4551","GNOM","IDNA","LGHT","BK4532","BK4548","BK4534","MRNA","BK4533"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668499884","title":"AETHLON MEDICAL与NORTH IMMUNOLOGY达成合并协议后，股价飙升467%至8.16美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2668499884","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668499884?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 21:44","pubTimestamp":1789652692,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4568","AEMD","BK4082","BK4583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668096118","title":"Aethlon Medical与North Immunology合并后股价飙升","url":"https://stock-news.laohu8.com/highlight/detail?id=2668096118","media":"路透中文","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668096118?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 19:31","pubTimestamp":1789644702,"startTime":"0","endTime":"0","summary":"BUZZ-Aethlon Medical与North Immunology合并后股价飙升9月17日-** 医疗设备开发商 Aethlon Medical（AEMD.O）与私营生物技术公司 North Immunology 达成全股票合并协议后，其股价在盘前交易中飙升 430%，至 7.58 美元** 若涨势得以维持，该股开盘价将创下自2026年6月以来的新高** 合并后公司将以“North Imm","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260917:nL4T4590XH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","AEMD","BK4583","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118582759","title":"Aethlon Medical宣布与North Immunology达成合并协议，盘前股价飙升87.4%至2.68美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118582759","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118582759?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 18:36","pubTimestamp":1789641419,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc股价在盘前交易中暴涨87.4%，报2.68美元。此前，该公司宣布已与North Immunology签署合并协议。这一重磅消息瞬间点燃市场热情，投资者竞相涌入，推动股价大幅攀升。Aethlon Medical的此番动作，标志着其在生物医药领域的战略布局迈出了关键一步。市场分析人士认为，此次合并有望整合双方优势资源，加速创新疗法的研发与商业化进程，前景值得期待。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4583","BK4082","BK4568","AEMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1121640138","title":"Aethlon Medical：合并前原股东持股约4.75%，North Immunology股东将掌控合并后公司约95.25%股权","url":"https://stock-news.laohu8.com/highlight/detail?id=1121640138","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1121640138?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 18:32","pubTimestamp":1789641129,"startTime":"0","endTime":"0","summary":"Aethlon Medical宣布，其与North Immunology的合并交易完成后，原Aethlon股东将持有合并后实体约4.75%的股份，而North Immunology股东则持有剩余约95.25%的股份。这一比例分配反映了双方在交易中的相对估值。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4583","AEMD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1195928257","title":"Aethlon Medical合并案揭晓：North Immunology原股东预计持有合并实体约95.25%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=1195928257","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1195928257?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 18:32","pubTimestamp":1789641128,"startTime":"0","endTime":"0","summary":"Aethlon Medical Inc——在即将完成的合并交易中，North Immunology现有股东预计将持有合并后公司约95.25%的股权。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["AEMD","BK4583","BK4082","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111255872","title":"Aethlon Medical与North Immunology合并，共推新型IL-13×IL-18双特异性抗体治疗特应性皮炎","url":"https://stock-news.laohu8.com/highlight/detail?id=1111255872","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111255872?lang=zh_cn&edition=fundamental","pubTime":"2026-09-17 18:31","pubTimestamp":1789641070,"startTime":"0","endTime":"0","summary":"Aethlon Medical与North Immunology宣布达成合并协议。此次合并旨在加速推进一款针对特应性皮炎的新型IL-13×IL-18双特异性抗体的临床开发。双方表示，这一战略整合将汇聚两家公司在免疫学与抗体工程领域的专长，有望为特应性皮炎患者带来更具针对性的治疗选择。分析人士指出，特应性皮炎治疗领域竞争日趋激烈，差异化靶点组合或将成为未来药物研发的重要方向。Aethlon Medical与North Immunology的此番联手，或许能为该领域注入新的变量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","BK4583","BK4082","AEMD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171725154","title":"Co-Diagnostics携手Readygo，共探血液分子即时检测——首站瞄准埃博拉病毒","url":"https://stock-news.laohu8.com/highlight/detail?id=1171725154","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171725154?lang=zh_cn&edition=fundamental","pubTime":"2026-09-16 20:46","pubTimestamp":1789562774,"startTime":"0","endTime":"0","summary":"Co-Diagnostics与Readygo宣布达成合作，双方将联手评估基于血液样本的分子检测技术，并致力于将其推向“需求点”场景下的实际应用。此次合作的首个研究方向，直指埃博拉病毒的快速筛查与诊断。双方表示，血液样本的分子检测若能在基层医疗点落地，将极大提升传染病防控的响应效率。Co-Diagnostics与Readygo的联手，或将为此类技术在全球公共卫生体系中的普及，提供一个值得关注的实践样本。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4568","CODX","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164691459","title":"吉利德科学扩大六项免许可费自愿授权协议，力推每年一次HIV预防药Lenacapavir","url":"https://stock-news.laohu8.com/highlight/detail?id=1164691459","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164691459?lang=zh_cn&edition=fundamental","pubTime":"2026-09-16 20:31","pubTimestamp":1789561872,"startTime":"0","endTime":"0","summary":"吉利德科学宣布，扩大其六项免许可费的自愿授权协议，覆盖其每年仅需注射一次的HIV预防药物Lenacapavir。此举旨在拓宽药物可及性，助力全球抗击艾滋病疫情。通过这一系列协议，吉利德希望加快该长效预防方案在中低收入国家的推广，以应对持续存在的公共卫生挑战。该举措不仅彰显了公司在全球健康公平方面的承诺，也为实现2030年终结艾滋病流行的目标注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU0289739699.SGD","GILD","BK4578","BIB","LU0889565916.HKD","IE00B7SZLL34.SGD","BK4550","LU1430594728.SGD","LU1674673428.USD","LU2089984988.USD","LU0823416689.USD","LU2324357040.USD","LU1023059063.AUD","LU1585245621.USD","TMED","LU1037948541.HKD","LU1066053197.SGD","BK4139","MEDI","SG9999015986.USD","IE00B19Z3B42.SGD","LU1934455277.USD","LU0965509101.SGD","LU2087621335.USD","BK4568","IBBQ","IE00BSNM7G36.USD","LU2468319806.SGD","SG9999015978.USD","LU0965509010.AUD","LU1057294990.SGD","LU0109394709.USD","IE0002270589.USD","BK4532","LU0859254822.USD","LU1066051498.USD","BK4585","BMED","LU0861579265.USD","LU2357627491.SGD","SG9999015945.SGD","LU0965509283.SGD","LU0234570918.USD","IE00B19Z3581.USD","BBH","LU0965508806.USD","LU0320765992.SGD","IBB","LU1571399168.USD","IE00BKVL7J92.USD","LU1778281490.HKD","LU2112291526.USD","IE00B3T34201.USD","LU1934455194.USD","BK4566","LU0122379950.USD","LU1674673691.USD","LU1839511570.USD","TBXU","IE00BZ1G4Q59.USD","LU0114720955.EUR","LU1037948897.HKD","SG9999015952.SGD","BK4583","BK4588","LU0058720904.USD","LU1061106388.HKD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667679102","title":"钨价两年九倍，“工业牙齿”打响全球争夺战","url":"https://stock-news.laohu8.com/highlight/detail?id=2667679102","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667679102?lang=zh_cn&edition=fundamental","pubTime":"2026-09-16 10:40","pubTimestamp":1789526401,"startTime":"0","endTime":"0","summary":"9月15日9时30分，A股开盘，翔鹭钨业一分钟内封死涨停，封单超过10亿元。消息面上，据央视财经报道，国际市场钨产业链核心中间产品价格两年上涨约9倍，美国、英国、越南、津巴布韦相继调整钨相关政策，全球钨资源争夺升温。两年九倍，钨价起飞钨的熔点是3422℃，自然界最高。硬度大、耐高温、抗腐蚀，它被形象地叫作“工业牙齿”。钨，这颗“工业牙齿”所咬合的，是整条制造业的神经末梢。","market":"us","thumbnail":" http://caiji.3g.cnfol.com/colect/202609/16/20260916126970.jpg","type":0,"news_type":0,"thumbnails":[" http://caiji.3g.cnfol.com/colect/202609/16/20260916126970.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/ggzixun/20260916/32371239.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["LU0348766576.USD","BK0084","BK0233","BK4568","BK0182","APT","LU2351347302.SGD","BK4086","000657","BK0102","LU2187417386.USD","BK0028","BK0155","BK0077","LU0348767384.USD","SGXZ49509284.SGD","BK0010","002378","600549","LU2929501877.USD","SGXZ81163826.USD","BK0188"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181550481","title":"Co-Diagnostics签署重要材料转让协议——与Readygo Diagnostics达成合作，2026年8月生效（SEC文件披露）","url":"https://stock-news.laohu8.com/highlight/detail?id=1181550481","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1181550481?lang=zh_cn&edition=fundamental","pubTime":"2026-09-16 04:08","pubTimestamp":1789502887,"startTime":"0","endTime":"0","summary":"Co-Diagnostics, Inc.宣布，其已于2026年8月与Readygo Diagnostics签订一项材料转让协议。这一消息源自其向美国证券交易委员会（SEC）提交的最新文件。此举标志着该公司在诊断技术合作领域迈出了重要一步，旨在通过资源共享与技术创新，进一步拓展其业务版图。此次协议的达成，不仅反映了Co-Diagnostics在行业内的积极布局，也预示着未来双方可能携手推出更具前瞻性的解决方案。不过，文件中并未透露更多交易细节，市场对此保持关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CODX","BK4568","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667621189","title":"健康快讯：一种用于磁共振成像检查的新造影剂可更早发现肺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=2667621189","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667621189?lang=zh_cn&edition=fundamental","pubTime":"2026-09-16 02:52","pubTimestamp":1789498325,"startTime":"0","endTime":"0","summary":"健康快讯：一种用于磁共振成像检查的新造影剂可更早发现肺癌《Health Rounds》荣获2026年出版商通讯奖“最佳科学通讯”奖项，每周二和周四发布。今天我们重点介绍一种可能改变游戏规则的磁共振成像实验性造影剂，它有望在肺癌肿瘤尚小、治疗选择更多时就发现病灶。新型造影剂可在MRI检查中发现微小肺部肿瘤研究人员发现，一种用于磁共振成像检查的新型造影剂，可能使医生在比目前更早的阶段诊断出肺癌。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nL4S4571FH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IYH","LU1043141123.HKD","LU2468319806.SGD","LU0466842654.USD","BK4581","IHE","LU1267930813.SGD","LU0203345920.USD","TRUH","IE00BLSP4239.USD","LU0912757837.SGD","PJP","LU1674673428.USD","MEDX","LU2602419157.SGD","LU2487616109.SGD","FHLC","LU1043141396.HKD","BK4585","LU2471134796.USD","LU1221951129.SGD","SG9999001176.USD","BK4592","IE00B4R5TH58.HKD","IE000MB6IJN5.SGD","LU1732799900.SGD","GDOC","JDOC","LU0820561818.USD","XLV","LU0210536198.USD","IE000M9KFDE8.USD","JNJ","VHT","LU0345770993.USD","LU0058720904.USD","LU1244550221.USD","FTXH","LU0345770308.USD","RXL","LU1629891620.HKD","IXJ","LU0072461881.USD","IE0002141913.USD","IE00B1BXHZ80.USD","LU0964807845.USD","BMED","IE0001KFT4U8.USD","BK4568","LU0545562505.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667296846","title":"Contineum 股价下跌 9.9%，原因是其与强生合作研发的抗抑郁药中期临床试验失败。","url":"https://stock-news.laohu8.com/highlight/detail?id=2667296846","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667296846?lang=zh_cn&edition=fundamental","pubTime":"2026-09-16 01:17","pubTimestamp":1789492646,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IE00BFTCPJ56.SGD","IE00B42XCP33.USD","JNJ","IE00B19Z3B42.SGD","LU1585245621.USD","LU1929549753.HKD","LU1162221912.USD","PJP","LU0545562505.USD","IBBJ","LU0432979614.USD","LU1674673691.USD","IBBQ","MEDX","LU2468319806.SGD","IE000SO60NU8.SGD","RXL","LU0072461881.USD","BMED","LU1629891620.HKD","LU0820561818.USD","TRUH","LU0289739699.SGD","IYH","VHT","FTXH","LU0792757196.USD","LU0689626769.HKD","MDTX","LU0345769631.USD","PSYK","XLV","FHLC","LU0889566641.SGD","LU2417539215.USD","JDOC","IXJ","IHE","LU1032955483.USD","BK4568","IE00BJT1NW94.SGD","IE00BFXG1179.USD","LU1430594728.SGD","LU0203345920.USD","LU2403377893.USD","LU1228905540.USD","GDOC","LU1244550577.SGD","LU0124676726.USD","LU1989771016.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1120765496","title":"吉利德科学携手巴西卫生部，共促Lenacapavir本地化生产新篇章","url":"https://stock-news.laohu8.com/highlight/detail?id=1120765496","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1120765496?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485331,"startTime":"0","endTime":"0","summary":"吉利德科学公司近日透露，正积极与巴西卫生部探索合作良机，旨在助力该国实现Lenacapavir药物的本土生产愿景。这一举措，无疑为巴西医药产业自主化进程注入了强劲动力。据悉，双方的洽谈聚焦于如何深化协作，以切实推进巴西卫生部既定的战略目标——即构建并强化Lenacapavir的本地制造能力。Lenacapavir，作为一款备受瞩目的长效抗逆转录病毒药物，其本地化生产若能落地，对巴西乃至更广泛地区的HIV防治工作意义深远。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015986.USD","LU1571399168.USD","LU0234570918.USD","BK4566","TBXU","LU0889565916.HKD","LU0058720904.USD","LU0882574055.USD","LU1934455277.USD","LU2087621335.USD","LU1934455194.USD","IBBQ","IE00B7SZLL34.SGD","LU0122379950.USD","GILD","LU0965509010.AUD","BIB","BMED","BK4550","LU1674673428.USD","LU2089984988.USD","LU0320765992.SGD","BK4588","LU0109394709.USD","LU0289739699.SGD","LU2324357040.USD","LU2112291526.USD","BK4139","LU1037948541.HKD","BBH","BK4568","LU0965509283.SGD","LU1839511570.USD","SG9999015952.SGD","LU1066053197.SGD","SG9999015945.SGD","TMED","LU1057294990.SGD","LU1023059063.AUD","IE00B19Z3581.USD","IE00BSNM7G36.USD","BK4578","BK4583","LU1674673691.USD","LU1061106388.HKD","IE00B19Z3B42.SGD","LU1066051498.USD","LU0965509101.SGD","LU2468319806.SGD","LU1934455863.HKD","LU0823416689.USD","LU1778281490.HKD","LU1037948897.HKD","LU1430594728.SGD","IE00B3T34201.USD","SG9999015978.USD","BK4532","IE0002270589.USD","LU0965508806.USD","LU1585245621.USD","BK4585","LU0114720955.EUR","LU0861579265.USD","IBB","LU0859254822.USD","MEDI","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU2357627491.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158863992","title":"吉利德科学：持续探索与泛美卫生组织合作，助力各国准备好并扩大长效艾滋病预防措施的普及","url":"https://stock-news.laohu8.com/highlight/detail?id=1158863992","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158863992?lang=zh_cn&edition=fundamental","pubTime":"2026-09-15 23:15","pubTimestamp":1789485330,"startTime":"0","endTime":"0","summary":"吉利德科学（Gilead Sciences）宣布，将继续探索与泛美卫生组织（PAHO）的合作机会，以支持各国做好充分准备，并推动长效艾滋病预防手段的可及性扩展。这一举措旨在强化全球公共卫生应对体系，尤其是针对中低收入国家的需求，通过技术转移、能力建设及供应链优化等途径，加快长效预防方案的落地与规模化应用。双方的合作重点在于应对实施层面的挑战，确保相关资源能够高效、公平地分配至最需要的人群，从而在更大范围内遏制HIV的传播。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B19Z3B42.SGD","IE00BKVL7J92.USD","LU2324357040.USD","SG9999015952.SGD","LU0122379950.USD","IE00B19Z3581.USD","LU1585245621.USD","BIB","SG9999015978.USD","BK4588","BK4566","IBB","LU1057294990.SGD","LU2087621335.USD","LU2357627491.SGD","BK4532","LU1066051498.USD","TMED","LU0965509101.SGD","BK4550","TBXU","BK4568","LU0058720904.USD","BK4585","LU0965509283.SGD","BK4583","IE0002270589.USD","LU0234570918.USD","LU1778281490.HKD","SG9999015986.USD","LU0859254822.USD","LU1037948541.HKD","LU0965508806.USD","LU2468319806.SGD","LU1674673691.USD","LU2112291526.USD","LU0861579265.USD","IE00BZ1G4Q59.USD","LU0289739699.SGD","BBH","BK4139","LU0823416689.USD","LU0114720955.EUR","IE00B7SZLL34.SGD","LU1934455194.USD","LU0889565916.HKD","BK4578","BMED","IBBQ","LU1934455277.USD","LU0965509010.AUD","LU1839511570.USD","LU1023059063.AUD","LU1066053197.SGD","SG9999015945.SGD","LU1037948897.HKD","GILD","MEDI","IE00BSNM7G36.USD","LU0882574055.USD","LU1571399168.USD","LU1674673428.USD","LU1061106388.HKD","LU0109394709.USD","LU1430594728.SGD","LU2089984988.USD","LU0320765992.SGD","LU1934455863.HKD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":74,"code":"91000000","status":"200"}]}}